Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Neely

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Stroke|February 18, 2016
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS TrialChee Tang Chin, Benjamin Neely, E Magnus Ohman, et al.
American Heart Journal|June 23, 2014
Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trialJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.
AJR. American Journal of Roentgenology|August 14, 2020
Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on MammographyLars J Grimm, Benjamin Neely, Rui Hou, et al.
JACC. Heart Failure|June 23, 2014
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failureTariq Ahmad, Mona Fiuzat, Benjamin Neely, et al.
Journal of the American Heart Association|November 6, 2016
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary SyndromesJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.
BMC Family Practice|November 19, 2021
Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trialLeah L Zullig, Mohammad Shahsahebi, Benjamin Neely, et al.
American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Stroke|February 18, 2016
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS TrialChee Tang Chin, Benjamin Neely, E Magnus Ohman, et al.
American Heart Journal|June 23, 2014
Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trialJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.
AJR. American Journal of Roentgenology|August 14, 2020
Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on MammographyLars J Grimm, Benjamin Neely, Rui Hou, et al.
JACC. Heart Failure|June 23, 2014
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failureTariq Ahmad, Mona Fiuzat, Benjamin Neely, et al.
Journal of the American Heart Association|November 6, 2016
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary SyndromesJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.
BMC Family Practice|November 19, 2021
Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trialLeah L Zullig, Mohammad Shahsahebi, Benjamin Neely, et al.
American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.
Pageof 3